The primary mechanisms of action include: Enhancing glucose-dependent insulin secretion from pancreatic beta cells, which helps lower blood glucose levels when they are elevated Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production [1] [2] Slowing gastric emptying , which moderates the rate at which nutrients enter the bloodstream Promoting satiety through central nervous system pathways, leading to reduced caloric intake [1] [2] These medications are peptide-based (and one fusion protein) and are temperature sensitive
They help raise insulin and suppress the hormone glucagon, which plays a role in both appetite and Type 2 diabetes
34%) and reduced liver fibrosis without worsening of steatohepatitis (37% vs
If youre on a GLP-1 medication Ozempic, Wegovy, Mounjaro and youve been told to add NAD+ to your protocol, youve probably encountered some version of the same pitch: NAD+ gives you the energy back that GLP-1 drugs take away
Start My Assessment Takes 5 minutes No commitment required
This can lead to higher blood sugar levels and difficulty regulating appetite
